Revenue and profits grew year-over-year, with consolidated revenue at INR 7,977 million and profit at INR 1,322 million. Interim dividend of INR 5 per share declared, and acquisitions in Ghana and India approved to drive future growth.Original document: Dr. Lal PathLabs Limited [LALPATHLAB] Interim…
Revenue and profits grew year-over-year, with consolidated revenue at INR 7,977 million and profit at INR 1,322 million. Interim dividend of INR 5 per share declared, and acquisitions in Ghana and India approved to drive future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
